SOURCE: Cavit Sciences, Inc.

March 09, 2007 08:00 ET

Cavit Sciences, Inc. Announces Research and Development Facilities

DELRAY BEACH, FL -- (MARKET WIRE) -- March 9, 2007 -- Cavit Sciences, Inc. ("Cavit") (OTCBB: CVIT) today announced that it has secured the required facilities for its laboratories, research and development, warehouse and corporate offices.

Cavit's plant is located in Miami in a research and technology complex. The facilities will provide ample room for the development of the food supplement and herbal line that Cavit obtained last month. The plants laboratories will be used for ongoing research and development of existing products and products being developed with innovation as our trend. The facilities will also accommodate Cavit's plant equipment, staff, and relocated corporate headquarters and allow for future expansion.

The core products in Cavit's supplement line will enhance and improve the prostate, maintain and support the cardiovascular system, and beneficially effect arthritis and osteoporosis. Superior results have been attained by individuals with the use of Cavit's products. These proven results are due to the research and testing of the most effective formulas with nutrients that support and supplement each other at the optimum dosage of each ingredient.

Shareholders and investors will be kept abreast of Cavit's plant progress and our marketing program.

Cavit Sciences, Inc. ("Cavit") is a biotechnology company engaged in developing treatments of cancer and viral infections. Additional information is available on the Company's website at:

Statements contained herein that are not historical fact may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that are subject to a variety of risks and uncertainties. Cavit's food supplements are not intended to diagnose, treat, cure or prevent any disease; they have not been evaluated by the Food and Drug Administration and the efficacy of these products has not been confirmed by FDA-approved research. There are a number of important factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statements made by Cavit. These factors include, but are not limited to: (i) the ability of Cavit to successfully raise financing, (ii) the ability of Cavit to finalize its manufacturing and distribution facilities, and (iii) the ability of Cavit to successfully commercialize its products in certain markets. Additional factors that would cause actual results to differ materially from those projected or suggested in any forward-looking statements are contained in Cavit's filings with the Securities and Exchange Commission, including those factors discussed under the caption "Risk Factors" for Cavit on Form 10-SB filed on October 16, 2006.

Contact Information